Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29909136 | 1.00 | ABCG2 (0.40) | ABCG2MAPTHCRTR1 | |
| SCHEMBL23576915 | 0.89 | ABCG2 (0.40) | ABCG2MAPTHCRTR1 | |
| SCHEMBL29909020 | 0.89 | ABCG2 (0.40) | ABCG2MAPTHCRTR1 | |
| SCHEMBL29909063 | 0.88 | ABCG2 (0.46) | ABCG2MAPTHCRTR1 | |
| SCHEMBL23601280 | 0.88 | ABCG2 (0.46) | ABCG2MAPTHCRTR1 | |
| SCHEMBL23577999 | 0.84 | ABCG2 (0.42) | ABCG2MAPTHCRTR1 | |
| SCHEMBL29909434 | 0.84 | ABCG2 (0.42) | ABCG2MAPTHCRTR1 | |
| SCHEMBL23576699 | 0.84 | ABCG2 (0.42) | ABCG2MAPTHCRTR1 | |
| SCHEMBL23576978 | 0.84 | ABCG2 (0.42) | ABCG2MAPTHCRTR1 | |
| SCHEMBL29909751 | 0.84 | ABCG2 (0.42) | ABCG2MAPTHCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220324866-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | GILEAD SCIENCES, INC. | 2022-10-13 | — | — | US | disclosed |
| WO-2021130638-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | CARNA BIOSCIENCES, INC. (JP) | 2021-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220324866-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | DGKG, DGKB, DGKK | ABCG2 4216/4885MAPT 4206/4885HCRTR1 4425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.